CIK 0001177648
- Non-accelerated filer
- Smaller reporting company
ENANTA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ENTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Entity type
- Operating
- EIN
- 043205099
- Phone
- +1 617-607-0800
- Business address
- 4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-01 | Adda Nathalie Sr. VP & Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −2,895 | 6,285 | ||
| 2022-03-21 | CARTER BRUCE L A Director | Option exercise | +6,000 | $25.58 | $153K | 6,000 |
| 2022-03-21 | CARTER BRUCE L A Director | Sale | −2,676 | $66.70 | $178K | 3,324 |
| 2022-03-21 | CARTER BRUCE L A Director | Sale | −307 | $67.23 | $21K | 3,017 |
| 2022-03-21 | CARTER BRUCE L A Director | Sale | −2,210 | $68.66 | $152K | 807 |
| 2022-03-21 | CARTER BRUCE L A Director | Sale | −807 | $69.52 | $56K | 0 |
| 2022-03-21 | CARTER BRUCE L A Director | Option exercise · Stock Option (Right to Buy) | −6,000 | 0 | ||
| 2022-03-03 | Vance Terry Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2022-03-03 | Russell Lesley Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2022-03-03 | Peterson Kristine Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2022-03-03 | Hata Yujiro S Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2022-03-03 | FOLETTA MARK G Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2022-03-03 | CARTER BRUCE L A Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2022-03-02 | Adda Nathalie Sr. VP & Chief Medical Officer | Option exercise | +12,481 | $43.46 | $542K | 47,463 |
| 2022-03-02 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −12,481 | $70.07 | $875K | 34,982 |
| 2022-03-02 | Adda Nathalie Sr. VP & Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −12,481 | 0 | ||
| 2022-03-01 | Adda Nathalie Sr. VP & Chief Medical Officer | Option exercise | +24,339 | $43.46 | $1.1M | 59,321 |
| 2022-03-01 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −24,239 | $70.26 | $1.7M | 35,082 |
| 2022-03-01 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −100 | $71.06 | $7K | 34,982 |
| 2022-03-01 | Adda Nathalie Sr. VP & Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −24,339 | 12,481 |
Page 13 of 19 · 377 trades